Fundraising news at Warwick
Over 750 biomarkers identified as potentials for early cancer screening test
Researchers have identified 788 biomarkers in blood that could be used to develop an early stage cancer screening test for the general population.
The study, led by the University of Sheffield, is the first to create a comprehensive list of relevant cancer blood biomarkers that have been researched in the last five years. The study also groups them by molecular function and records the technologies that can be used to detect them.
The team - from the Universities of Sheffield, Coventry and Warwick - started with over 19,000 scientific studies published over the last five years that investigated blood based biomarkers. Systematic review methods - including ruling out studies in fewer than 50 patients - reduced this to 4,000 studies from which the final biomarker list was compiled.